Millennium Management LLC increased its position in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 200.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,841 shares of the technology company's stock after acquiring an additional 29,929 shares during the period. Millennium Management LLC owned about 0.22% of Simulations Plus worth $1,251,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently bought and sold shares of the company. Janus Henderson Group PLC grew its position in Simulations Plus by 7,753.3% in the fourth quarter. Janus Henderson Group PLC now owns 542,899 shares of the technology company's stock worth $15,141,000 after acquiring an additional 535,986 shares in the last quarter. Royce & Associates LP raised its holdings in shares of Simulations Plus by 56.6% during the 4th quarter. Royce & Associates LP now owns 371,797 shares of the technology company's stock valued at $10,369,000 after purchasing an additional 134,381 shares in the last quarter. Nicholas Company Inc. acquired a new stake in shares of Simulations Plus in the 4th quarter valued at $3,418,000. Kennedy Capital Management LLC lifted its stake in shares of Simulations Plus by 59.4% in the 4th quarter. Kennedy Capital Management LLC now owns 289,286 shares of the technology company's stock valued at $8,068,000 after purchasing an additional 107,766 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in Simulations Plus by 210.7% in the fourth quarter. JPMorgan Chase & Co. now owns 147,154 shares of the technology company's stock worth $4,104,000 after purchasing an additional 99,789 shares in the last quarter. Institutional investors and hedge funds own 78.08% of the company's stock.
Simulations Plus Trading Down 0.9%
NASDAQ:SLP traded down $0.24 during mid-day trading on Friday, hitting $27.55. 228,576 shares of the company's stock traded hands, compared to its average volume of 224,575. The firm has a market capitalization of $554.06 million, a price-to-earnings ratio of 68.88 and a beta of 0.97. The firm has a 50 day moving average of $30.63 and a two-hundred day moving average of $30.37. Simulations Plus, Inc. has a 12 month low of $23.01 and a 12 month high of $50.11.
Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its quarterly earnings data on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.06. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The company had revenue of $22.43 million for the quarter, compared to the consensus estimate of $21.93 million. During the same quarter in the previous year, the firm posted $0.20 EPS. The business's revenue was up 22.5% compared to the same quarter last year. As a group, equities research analysts expect that Simulations Plus, Inc. will post 1.09 earnings per share for the current year.
Analyst Ratings Changes
A number of brokerages recently weighed in on SLP. Wall Street Zen raised Simulations Plus from a "sell" rating to a "hold" rating in a research note on Monday, April 28th. KeyCorp lifted their price target on shares of Simulations Plus from $32.00 to $40.00 and gave the company an "overweight" rating in a research report on Wednesday, April 16th. Finally, William Blair restated an "outperform" rating on shares of Simulations Plus in a research note on Tuesday. Two research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $50.00.
Read Our Latest Stock Analysis on Simulations Plus
Insiders Place Their Bets
In other news, Director Walter S. Woltosz sold 20,000 shares of the company's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $33.51, for a total value of $670,200.00. Following the sale, the director now directly owns 3,344,157 shares in the company, valued at approximately $112,062,701.07. This represents a 0.59% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 19.40% of the company's stock.
Simulations Plus Profile
(
Free Report)
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Featured Articles

Before you consider Simulations Plus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Simulations Plus wasn't on the list.
While Simulations Plus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.